Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly

Pathological folding and aggregation of the amyloid  -protein (A ) are widely perceived as central to under- standing Alzheimer's disease (AD) at the molecular level. Experimental approaches to study A self-assembly are lim- ited, because most relevant aggregates are quasi-stable and inhomogeneous. In contrast, simulations can provide signifi- cant insights into the problem, including specific sites in the molecule that would be attractive for drug targeting and de- tails of the assembly pathways leading to the production of toxic assemblies. Here we review computer simulation ap- proaches to understanding the structural biology of A . We discuss the ways in which these simulations help guide ex- perimental work, and in turn, how experimental results guide the development of theoretical and simulation approaches that may be of general utility in understanding pathologic protein folding and assembly.

[1]  Zhou,et al.  First-Order Disorder-to-Order Transition in an Isolated Homopolymer Model. , 1996, Physical review letters.

[2]  D. Teplow,et al.  Quasielastic Light Scattering Study of Amyloid β-Protein Fibril Formation , 2006 .

[3]  J R Ghilardi,et al.  Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. , 2000, Biochemistry.

[4]  D. C. Rapaport,et al.  The Art of Molecular Dynamics Simulation , 1997 .

[5]  A. Giuliani,et al.  Early events in protein aggregation: Molecular flexibility and hydrophobicity/charge interaction in amyloid peptides as studied by molecular dynamics simulations , 2004, Proteins.

[6]  K. Iwata,et al.  The Alzheimer's peptide a beta adopts a collapsed coil structure in water. , 2000, Journal of structural biology.

[7]  Brigita Urbanc,et al.  Ab initio discrete molecular dynamics approach to protein folding and aggregation. , 2006, Methods in enzymology.

[8]  Ruth Nussinov,et al.  Atomic-Level Description of Amyloid β-Dimer Formation , 2006 .

[9]  G. Bitan,et al.  Amyloid β-protein: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform , 2005 .

[10]  Barkema,et al.  Event-Based Relaxation of Continuous Disordered Systems. , 1996, Physical review letters.

[11]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[12]  Y. Okamoto,et al.  Molecular dynamics, Langevin, and hybrid Monte Carlo simulations in multicanonical ensemble , 1996, physics/9710018.

[13]  S. Younkin,et al.  Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain , 1995, The Journal of Biological Chemistry.

[14]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[15]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[16]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[17]  O. Gursky,et al.  Temperature-dependent β-sheet formation in β-amyloid Aβ1–40 peptide in water: uncoupling β-structure folding from aggregation , 2000 .

[18]  D. Thirumalai,et al.  Dissecting the assembly of A β 16-22 amyloid peptides into antiparallel β-sheets , 2002 .

[19]  G. Bitan,et al.  Amyloid β‐protein monomer structure: A computational and experimental study , 2006, Protein science : a publication of the Protein Society.

[20]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[21]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[22]  P. Lansbury,et al.  Peptide Models of a Hydrophobic Cluster at the C-Terminus of the Beta-Amyloid Protein , 1994 .

[23]  P. Wolynes,et al.  Folding dynamics with nonadditive forces: A simulation study of a designed helical protein and a random heteropolymer , 1999 .

[24]  A. Cohen,et al.  Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins , 1959, Nature.

[25]  F. LaFerla,et al.  Amyloid β-Peptide: The Inside Story , 2004 .

[26]  D. Downing,et al.  Fibril formation by amyloid-beta proteins may involve beta-helical protofibrils. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[27]  T. Wisniewski,et al.  Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. , 1991, Biochemical and biophysical research communications.

[28]  T. Benzinger,et al.  Two-Dimensional Structure of β-Amyloid(10−35) Fibrils† , 2000 .

[29]  Gerhard Hummer,et al.  Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments , 2005 .

[30]  M. Mezei Adaptive umbrella sampling: Self-consistent determination of the non-Boltzmann bias , 1987 .

[31]  A. Giuliani,et al.  Protein aggregation/folding: the role of deterministic singularities of sequence hydrophobicity as determined by nonlinear signal analysis of acylphosphatase and Abeta(1-40). , 2003, Biophysical journal.

[32]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Tjernberg,et al.  Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment. , 2002, The Biochemical journal.

[34]  S. Younkin,et al.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). , 1995, The Journal of biological chemistry.

[35]  D. Selkoe,et al.  Title Amyloid β-protein fibrillogenesis . Structure and biological activity of protofibrillar intermediates , 1999 .

[36]  H. Stanley,et al.  Discrete molecular dynamics simulations of peptide aggregation. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[37]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[38]  B. Bagchi,et al.  Contact pair dynamics during folding of two small proteins: chicken villin head piece and the Alzheimer protein beta-amyloid. , 2004, The Journal of chemical physics.

[39]  S. Santini,et al.  In Silico Assembly of Alzheimer's Aβ16-22 Peptide into β-Sheets , 2004 .

[40]  Brigita Urbanc,et al.  In silico study of amyloid β-protein folding and oligomerization , 2004 .

[41]  C. Glabe Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Abeta. , 2005, Sub-cellular biochemistry.

[42]  J. J. Balbach,et al.  Supramolecular Structure in Full-Length Alzheimer's β-Amyloid Fibrils: Evidence for a Parallel β-Sheet Organization from Solid-State Nuclear Magnetic Resonance , 2002 .

[43]  W. Klein ADDLs & protofibrils—the missing links? , 2002, Neurobiology of Aging.

[44]  K. Abromeit Music Received , 2023, Notes.

[45]  Marcela Colombres,et al.  Structure and function of amyloid in Alzheimer's disease , 2004, Progress in Neurobiology.

[46]  I. Kang,et al.  Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's Disease* , 2002, The Journal of Biological Chemistry.

[47]  E I Shakhnovich,et al.  Identifying the protein folding nucleus using molecular dynamics. , 1998, Journal of molecular biology.

[48]  C. Hall,et al.  Kinetics of Fibril Formation by Polyalanine Peptides* , 2005, Journal of Biological Chemistry.

[49]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[50]  D. Walsh,et al.  Amyloid β-Protein Fibrillogenesis , 1997, The Journal of Biological Chemistry.

[51]  J. J. Balbach,et al.  Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. , 2004, Biophysical journal.

[52]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[53]  A. V. Smith,et al.  Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model. , 2001, Journal of molecular biology.

[54]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[55]  D. Teplow,et al.  Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.

[56]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[57]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[58]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.

[59]  Francesca Massi,et al.  Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .

[60]  C. Hall,et al.  α‐Helix formation: Discontinuous molecular dynamics on an intermediate‐resolution protein model , 2001, Proteins.

[61]  A. di Nola,et al.  Misfolding of the amyloid β‐protein: A molecular dynamics study , 2005 .

[62]  Normand Mousseau,et al.  Exploring the energy landscape of proteins: A characterization of the activation-relaxation technique , 2002 .

[63]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils , 2000 .

[64]  H. Stanley,et al.  Discrete molecular dynamics studies of the folding of a protein-like model. , 1998, Folding & design.

[65]  D Thirumalai,et al.  Probing the initial stage of aggregation of the Abeta(10-35)-protein: assessing the propensity for peptide dimerization. , 2005, Journal of molecular biology.

[66]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[67]  C. Mousseau Exploring the Early Steps of Amyloid Peptide Aggregation by , 2005 .

[68]  J. Straub,et al.  A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization. , 2003, Journal of the American Chemical Society.

[69]  N. Mousseau,et al.  Exploring the early steps of amyloid peptide aggregation by computers. , 2006, Accounts of chemical research.

[70]  G. Favrin,et al.  Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces. , 2004, Biophysical journal.

[71]  C. Hall,et al.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Straub,et al.  Long time dynamic simulations: exploring the folding pathways of an Alzheimer's amyloid Abeta-peptide. , 2002, Accounts of chemical research.

[73]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Parisi,et al.  Simulated tempering: a new Monte Carlo scheme , 1992, hep-lat/9205018.

[75]  J. Straub,et al.  Aqueous urea solution destabilizes Aβ16–22 oligomers , 2004 .

[76]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[77]  R. Nussinov,et al.  Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Straub,et al.  Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. , 2001, Biophysical journal.

[79]  R. Stough Solvent and mutation effects on the nucleation of amyloid-protein folding , 2005 .

[80]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[81]  C. Finch,et al.  Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .

[82]  Martin Karplus,et al.  Molecular dynamics of biological macromolecules: A brief history and perspective , 2003, Biopolymers.

[83]  Martin Karplus,et al.  Probability Distributions for Complex Systems: Adaptive Umbrella Sampling of the Potential Energy , 1998 .

[84]  M. Levitt A simplified representation of protein conformations for rapid simulation of protein folding. , 1976, Journal of molecular biology.

[85]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[86]  R. Tycko,et al.  Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. , 2005, Biochemistry.

[87]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[88]  N. Mousseau,et al.  Dynamics of lennard-jones clusters: A characterization of the activation-relaxation technique , 2000 .

[89]  Gerd Buntkowsky,et al.  Solid State NMR Reveals a pH-dependent Antiparallel β-Sheet Registry in Fibrils Formed by a β-Amyloid Peptide , 2004 .

[90]  D. Thirumalai,et al.  Molecular crowding enhances native state stability and refolding rates of globular proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[91]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[92]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[93]  Yundong Wu,et al.  A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35). , 2005, Journal of the American Chemical Society.

[94]  N Casey,et al.  Residual structure in the Alzheimer's disease peptide: probing the origin of a central hydrophobic cluster. , 1998, Folding & design.

[95]  S. Santini,et al.  Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide Assembly , 2004 .

[96]  Eric J. Simon,et al.  Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.

[97]  A V Smith,et al.  Assembly of a tetrameric α‐helical bundle: Computer simulations on an intermediate‐resolution protein model , 2001, Proteins.

[98]  J. Straub,et al.  Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide. , 2001, Biophysical journal.

[99]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[100]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[101]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[102]  Magnus Palmblad,et al.  Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers* , 2002, The Journal of Biological Chemistry.

[103]  A. Baumketner,et al.  Free energy landscapes for amyloidogenic tetrapeptides dimerization. , 2005, Biophysical journal.

[104]  T. Benzinger,et al.  Propagating structure of Alzheimer’s β-amyloid(10–35) is parallel β-sheet with residues in exact register , 1998 .

[105]  M. Kidd ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY. , 1964, Brain : a journal of neurology.

[106]  M. Karplus,et al.  Folding thermodynamics of a model three-helix-bundle protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[107]  How do proteins fold and why , 2007 .

[108]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[109]  G. Bitan,et al.  Elucidation of Primary Structure Elements Controlling Early Amyloid β-Protein Oligomerization* , 2003, Journal of Biological Chemistry.

[110]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[111]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[112]  H. Stanley,et al.  Molecular Dynamics Simulation of Amyloid β Dimer Formation , 2004, physics/0403040.

[113]  D. Eisenberg,et al.  Atomic solvation parameters applied to molecular dynamics of proteins in solution , 1992, Protein science : a publication of the Protein Society.

[114]  Scott Brown,et al.  Influence of denatured and intermediate states of folding on protein aggregation , 2005, Protein science : a publication of the Protein Society.

[115]  Yuko Okamoto,et al.  Generalized-ensemble algorithms: enhanced sampling techniques for Monte Carlo and molecular dynamics simulations. , 2003, Journal of molecular graphics & modelling.

[116]  C. Hall,et al.  Phase diagrams describing fibrillization by polyalanine peptides. , 2004, Biophysical journal.

[117]  Feng Ding,et al.  Simple but predictive protein models. , 2005, Trends in biotechnology.

[118]  J. Sipe Amyloid proteins : the beta sheet conformation and disease , 2005 .

[119]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[120]  K. Iqbal,et al.  Alzheimer's disease : biology, diagnosis, and therapeutics , 1996 .

[121]  Eric J. Sorin,et al.  How well can simulation predict protein folding kinetics and thermodynamics? , 2005, Annual review of biophysics and biomolecular structure.

[122]  J. Straub,et al.  Charge states rather than propensity for β‐structure determine enhanced fibrillogenesis in wild‐type Alzheimer's β‐amyloid peptide compared to E22Q Dutch mutant , 2002 .

[123]  Long Time Dynamic Simulations: Exploring the Folding Pathways of an Alzheimer′s Amyloid Aβ‐Peptide , 2002 .

[124]  M. Karplus,et al.  Equilibrium thermodynamics of homopolymers and clusters: Molecular dynamics and Monte Carlo simulations of systems with square-well interactions , 1997 .

[125]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[126]  D. Butterfield,et al.  The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. , 2005, Biochimica et biophysica acta.

[127]  D. Teplow,et al.  On the nucleation of amyloid beta-protein monomer folding. , 2005, Protein science : a publication of the Protein Society.

[128]  U H Hansmann,et al.  New Monte Carlo algorithms for protein folding. , 1999, Current opinion in structural biology.

[129]  M. Karplus,et al.  Folding of a model three-helix bundle protein: a thermodynamic and kinetic analysis. , 1999, Journal of molecular biology.

[130]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[131]  J. Borreguero,et al.  Mechanism for the α‐helix to β‐hairpin transition , 2003, Proteins.

[132]  J. Brewer,et al.  Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .

[133]  C. Barrow,et al.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.

[134]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[135]  P. Keller,et al.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. , 2005, Journal of neurochemistry.

[136]  Shoji Takada,et al.  How protein thermodynamics and folding mechanisms are altered by the chaperonin cage: Molecular simulations , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[137]  Scott Brown,et al.  Coarse-grained sequences for protein folding and design , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[138]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[139]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[140]  T. Head-Gordon,et al.  Minimalist models for protein folding and design. , 2003, Current opinion in structural biology.

[141]  Francesca Massi,et al.  Structural and dynamical analysis of the hydration of the Alzheimer's β‐amyloid peptide , 2003, J. Comput. Chem..

[142]  Roger D Kamm,et al.  Kinetic control of dimer structure formation in amyloid fibrillogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Y. Ishii,et al.  Capturing intermediate structures of Alzheimer's β-amyloid, Aβ(1-40), by solid-state NMR spectroscopy , 2005 .

[144]  Jianpeng Ma,et al.  Conformational transition of amyloid β-peptide , 2005 .

[145]  Robert Schleif Modeling and Studying Proteins with Molecular Dynamics , 2004, Numerical Computer Methods, Part D.

[146]  D. Selkoe,et al.  X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[147]  Valentina Tozzini,et al.  Coarse-grained models for proteins. , 2005, Current opinion in structural biology.

[148]  E. Wijsman,et al.  Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. , 1992, American journal of human genetics.

[149]  H. Stanley,et al.  Solvent and mutation effects on the nucleation of amyloid beta-protein folding. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[150]  M. Karplus,et al.  Solution conformations and thermodynamics of structured peptides: molecular dynamics simulation with an implicit solvation model. , 1998, Journal of molecular biology.

[151]  J. Udgaonkar,et al.  How do proteins fold , 1997 .

[152]  Andrij Baumketner,et al.  Structure of the 21–30 fragment of amyloid β‐protein , 2006 .

[153]  Modeling the α-helix to β-hairpin transition mechanism and the formation of oligomeric aggregates of the fibrillogenic peptide Aβ(12-28): insights from all-atom molecular dynamics simulations , 2004 .

[154]  S. Buldyrev,et al.  Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model. , 2004, Biophysical journal.

[155]  A. Kidera,et al.  Multicanonical Ensemble Generated by Molecular Dynamics Simulation for Enhanced Conformational Sampling of Peptides , 1997 .